160 related articles for article (PubMed ID: 14604832)
1. Regulation of endogenous reactive oxygen species in platelets can reverse aggregation.
Clutton P; Miermont A; Freedman JE
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):187-92. PubMed ID: 14604832
[TBL] [Abstract][Full Text] [Related]
2. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets.
Fleming I; Schulz C; Fichtlscherer B; Kemp BE; Fisslthaler B; Busse R
Thromb Haemost; 2003 Nov; 90(5):863-71. PubMed ID: 14597982
[TBL] [Abstract][Full Text] [Related]
3. Pyridoxine improves platelet nitric oxide synthase dysfunction induced by advanced glycation end products in vitro.
Han Y; Liu Y; Mi Q; Xie L; Huang Y; Jiang Q; Chen Q; Ferro A; Liu N; Ji Y
Int J Vitam Nutr Res; 2010 Jun; 80(3):168-77. PubMed ID: 21234858
[TBL] [Abstract][Full Text] [Related]
4. Pyridoxine increases nitric oxide biosynthesis in human platelets.
Wu Y; Liu Y; Han Y; Cui B; Mi Q; Huang Y; Wang L; Jiang Q; Chen Q; Liu N; Ferro A; Ji Y
Int J Vitam Nutr Res; 2009 Mar; 79(2):95-103. PubMed ID: 20108211
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine decreases platelet NO level via protein kinase C activation.
Signorello MG; Segantin A; Passalacqua M; Leoncini G
Nitric Oxide; 2009 Mar; 20(2):104-13. PubMed ID: 19100855
[TBL] [Abstract][Full Text] [Related]
6. alpha-Tocopherol and protein kinase C inhibition enhance platelet-derived nitric oxide release.
Freedman JE; Li L; Sauter R; Keaney JF JR
FASEB J; 2000 Dec; 14(15):2377-9. PubMed ID: 11024007
[TBL] [Abstract][Full Text] [Related]
7. Role of inorganic nitrate and nitrite in driving nitric oxide-cGMP-mediated inhibition of platelet aggregation in vitro and in vivo.
Apostoli GL; Solomon A; Smallwood MJ; Winyard PG; Emerson M
J Thromb Haemost; 2014 Nov; 12(11):1880-9. PubMed ID: 25163536
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase.
Rukoyatkina N; Walter U; Friebe A; Gambaryan S
Thromb Haemost; 2011 Nov; 106(5):922-33. PubMed ID: 21800013
[TBL] [Abstract][Full Text] [Related]
9. The effects of tamoxifen and its metabolites on platelet function and release of reactive oxygen intermediates.
Vitseva O; Flockhart DA; Jin Y; Varghese S; Freedman JE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1144-50. PubMed ID: 15509721
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release.
Chakrabarti S; Clutton P; Varghese S; Cox D; Mascelli MA; Freedman JE
Thromb Res; 2004; 113(3-4):225-33. PubMed ID: 15140587
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
Irwin C; Roberts W; Naseem KM
Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
[TBL] [Abstract][Full Text] [Related]
12. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation.
Ozüyaman B; Gödecke A; Küsters S; Kirchhoff E; Scharf RE; Schrader J
Thromb Haemost; 2005 Jun; 93(6):1161-7. PubMed ID: 15968403
[TBL] [Abstract][Full Text] [Related]
13. NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity.
Gambaryan S; Kobsar A; Hartmann S; Birschmann I; Kuhlencordt PJ; Müller-Esterl W; Lohmann SM; Walter U
J Thromb Haemost; 2008 Aug; 6(8):1376-84. PubMed ID: 18485089
[TBL] [Abstract][Full Text] [Related]
14. Constitutively activated phosphatidylinositol 3-kinase primes platelets from patients with chronic myelogenous leukemia for thrombopoietin-induced aggregation.
Kubota Y; Tanaka T; Ohnishi H; Kitanaka A; Okutani Y; Taminato T; Ishida T; Kamano H
Leukemia; 2004 Jun; 18(6):1127-37. PubMed ID: 15085152
[TBL] [Abstract][Full Text] [Related]
15. Intraplatelet tetrahydrobiopterin plays an important role in regulating canine coronary arterial thrombosis by modulating intraplatelet nitric oxide and superoxide generation.
Kanaya S; Ikeda H; Haramaki N; Murohara T; Imaizumi T
Circulation; 2001 Nov; 104(20):2478-84. PubMed ID: 11705828
[TBL] [Abstract][Full Text] [Related]
16. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release.
Freedman JE; Parker C; Li L; Perlman JA; Frei B; Ivanov V; Deak LR; Iafrati MD; Folts JD
Circulation; 2001 Jun; 103(23):2792-8. PubMed ID: 11401934
[TBL] [Abstract][Full Text] [Related]
17. The arachidonic acid effect on platelet nitric oxide level.
Signorello MG; Segantin A; Leoncini G
Biochim Biophys Acta; 2009 Nov; 1791(11):1084-92. PubMed ID: 19615463
[TBL] [Abstract][Full Text] [Related]
18. Alterations in platelet Ca2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production.
Schaeffer G; Wascher TC; Kostner GM; Graier WF
Diabetologia; 1999 Feb; 42(2):167-76. PubMed ID: 10064096
[TBL] [Abstract][Full Text] [Related]
19. Calreticulin Transacetylase mediated activation of human platelet nitric oxide synthase by acetyl group donor compounds.
Kumar A; Sushama A; Manral S; Sinha R; Joshi R; Singh U; Rohil V; Prasad AK; Parmar VS; Raj HG
Nitric Oxide; 2012 Jan; 26(1):9-19. PubMed ID: 22100620
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen promotes superoxide production in platelets by activation of PI3-kinase and NADPH oxidase pathways.
Shah VP; Chegini HA; Vishneski SR; Weatherman RV; Blackmore PF; Dobrydneva Y
Thromb Res; 2012 Jan; 129(1):36-42. PubMed ID: 21875743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
